Opko Health, Inc.
OPK
$1.34
-$0.05-3.60%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 642.07M | 664.03M | 689.41M | 713.14M | 711.41M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 642.07M | 664.03M | 689.41M | 713.14M | 711.41M |
| Cost of Revenue | 510.10M | 541.63M | 558.50M | 573.88M | 601.06M |
| Gross Profit | 131.97M | 122.40M | 130.91M | 139.27M | 110.35M |
| SG&A Expenses | 239.52M | 283.92M | 293.14M | 304.22M | 310.07M |
| Depreciation & Amortization | 79.18M | 80.08M | 81.06M | 82.63M | 83.78M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 855.87M | 931.59M | 958.66M | 986.70M | 1.02B |
| Operating Income | -213.81M | -267.57M | -269.25M | -273.56M | -309.48M |
| Income Before Tax | -159.50M | -152.51M | -578.00K | -10.38M | -117.86M |
| Income Tax Expenses | 20.89M | 24.62M | 38.42M | 42.84M | 15.88M |
| Earnings from Continuing Operations | -180.40 | -177.14 | -39.00 | -53.22 | -133.73 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -180.40M | -177.14M | -39.00M | -53.22M | -133.73M |
| EBIT | -213.81M | -267.57M | -269.25M | -273.56M | -309.48M |
| EBITDA | -120.52M | -172.85M | -173.41M | -175.38M | -209.36M |
| EPS Basic | -0.24 | -0.23 | -0.06 | -0.07 | -0.18 |
| Normalized Basic EPS | -0.11 | -0.17 | -0.05 | -0.06 | -0.27 |
| EPS Diluted | -0.24 | -0.24 | -0.07 | -0.08 | -0.19 |
| Normalized Diluted EPS | -0.15 | -0.18 | -0.06 | -0.06 | -0.23 |
| Average Basic Shares Outstanding | 2.91B | 2.83B | 2.74B | 2.78B | 2.85B |
| Average Diluted Shares Outstanding | 3.19B | 3.41B | 3.32B | 3.35B | 3.15B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |